Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Medicale (MCLE) over the last 4 years, with Q3 2025 value amounting to -$8654.0.

  • Medicale's Net Income towards Common Stockholders changed N/A to -$8654.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$18657.0, marking a year-over-year change of. This contributed to the annual value of -$33652.0 for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Medicale's Net Income towards Common Stockholders is -$8654.0.
  • Medicale's Net Income towards Common Stockholders' 5-year high stood at $455.0 during Q4 2022, with a 5-year trough of -$8654.0 in Q3 2025.
  • Over the past 3 years, Medicale's median Net Income towards Common Stockholders value was -$3575.0 (recorded in 2025), while the average stood at -$3749.1.
  • Within the past 5 years, the most significant YoY rise in Medicale's Net Income towards Common Stockholders was 17583.33% (2022), while the steepest drop was 9083.55% (2022).
  • Over the past 3 years, Medicale's Net Income towards Common Stockholders (Quarter) stood at -$600.0 in 2021, then skyrocketed by 175.83% to $455.0 in 2022, then crashed by 2001.98% to -$8654.0 in 2025.
  • Its Net Income towards Common Stockholders stands at -$8654.0 for Q3 2025, versus -$3575.0 for Q2 2025 and -$6428.0 for Q1 2025.